Aspirin desensitization: Difference between revisions
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Rapid aspirin desensitization is required when continued [[aspirin]] administration is urgent and essential (e.g. [[acute coronary syndrome]]). A rapid protocol can be used <ref>[http://www.theannals.com/cgi/ | Rapid aspirin desensitization is required when continued [[aspirin]] administration is urgent and essential (e.g. [[acute coronary syndrome]]). A rapid protocol can be used <ref name="pmid17200429">{{cite journal |author=Page NA, Schroeder WS |title=Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy |journal=[[The Annals of Pharmacotherapy]] |volume=41 |issue=1 |pages=61–7 |year=2007 |month=January |pmid=17200429 |doi=10.1345/aph.1H437 |url=http://www.theannals.com/cgi/pmidlookup?view=long&pmid=17200429 |issn= |accessdate=2010-07-01}}</ref>: | ||
== Protocol for Aspirin Desensitization: == | == Protocol for Aspirin Desensitization: == | ||
Revision as of 15:40, 1 July 2010
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Keri Shafer, M.D.
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Rapid aspirin desensitization is required when continued aspirin administration is urgent and essential (e.g. acute coronary syndrome). A rapid protocol can be used [1]:
Protocol for Aspirin Desensitization:
The dose of aspirin is increased every 15 minutes until the maximum dose of aspirin is administered:
Dose #
- 0.1 mg
- 0.3 mg
- 1 mg
- 3 mg
- 10 mg
- 20 mg
- 40 mg
- 81 mg
- 162 mg
- 325 mg
References
- ↑ Page NA, Schroeder WS (2007). "Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy". The Annals of Pharmacotherapy. 41 (1): 61–7. doi:10.1345/aph.1H437. PMID 17200429. Retrieved 2010-07-01. Unknown parameter
|month=ignored (help)